Upstream Bio (UPB) News Today $8.96 +0.15 (+1.70%) As of 04/24/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Upstream Bio (NASDAQ:UPB) Trading 7.2% Higher - Here's What HappenedUpstream Bio (NASDAQ:UPB) Trading 7.2% Higher - Should You Buy?April 23 at 1:24 PM | marketbeat.comBain Capital Life Sciences Investors LLC Acquires New Holdings in Upstream Bio, Inc. (NASDAQ:UPB)Bain Capital Life Sciences Investors LLC purchased a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,295,322 shares of theApril 23 at 6:54 AM | marketbeat.comUpstream Bio: Verekitug, A Longer-Acting Dupixent? - Key Data Is ImminentApril 17, 2025 | seekingalpha.comFmr LLC Purchases New Position in Upstream Bio, Inc. (NASDAQ:UPB)Fmr LLC acquired a new position in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 7,176,187 shares of the company's stock, valued at approximately $117,977,000. Fmr LLC ownedApril 16, 2025 | marketbeat.comUpstream Bio Stock Price, Quotes and Forecasts | NASDAQ:UPB | BenzingaApril 11, 2025 | benzinga.comUpstream Bio (NASDAQ:UPB) Is In A Good Position To Deliver On Growth PlansApril 11, 2025 | finance.yahoo.comAlliancebernstein L.P. Invests $18.27 Million in Upstream Bio, Inc. (NASDAQ:UPB)Alliancebernstein L.P. bought a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,111,337 shares of the company's stock, valued at approximApril 9, 2025 | marketbeat.comWellington Management Group LLP Makes New $25.63 Million Investment in Upstream Bio, Inc. (NASDAQ:UPB)Wellington Management Group LLP bought a new stake in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,583,154 shares of the company's stock, valued at approxiApril 9, 2025 | marketbeat.comNorges Bank Invests $16.44 Million in Upstream Bio, Inc. (NASDAQ:UPB)Norges Bank acquired a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,000,000 shares of the company's stock, valued at approximately $16,440,000. NorgeApril 9, 2025 | marketbeat.comUpstream Bio, Inc.'s Lock-Up Period Will Expire on April 9th (NASDAQ:UPB)Upstream Bio's (NASDAQ:UPB - Get Free Report) lock-up period is set to end on Wednesday, April 9th. Upstream Bio had issued 15,000,000 shares in its IPO on October 11th. The total size of the offering was $255,000,000 based on an initial share price of $17.00. After the expiration of Upstream Bio's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.April 3, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Invests $2.23 Million in Upstream Bio, Inc. (NASDAQ:UPB)Charles Schwab Investment Management Inc. bought a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 135,323 shares of the company's stock, valued at approximaMarch 30, 2025 | marketbeat.comBank of New York Mellon Corp Invests $607,000 in Upstream Bio, Inc. (NASDAQ:UPB)Bank of New York Mellon Corp purchased a new stake in shares of Upstream Bio, Inc. (NASDAQ:UPB - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 36,913 shares of the company's stock, valued at approximatelMarch 27, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Stock Price Down 7.3% - Time to Sell?Upstream Bio (NASDAQ:UPB) Trading Down 7.3% - Time to Sell?March 19, 2025 | marketbeat.comWilliam Blair Forecasts Increased Earnings for Upstream BioUpstream Bio, Inc. (NASDAQ:UPB - Free Report) - Stock analysts at William Blair upped their Q1 2025 EPS estimates for shares of Upstream Bio in a research note issued to investors on Wednesday, March 12th. William Blair analyst M. Phipps now forecasts that the company will post earnings per shareMarch 15, 2025 | marketbeat.comUpstream Bio’s Financial Results and Strategic ProgressMarch 13, 2025 | tipranks.comUpstream Bio, Inc. Completes Enrollment in Phase 2 Trial of Verekitug for Chronic Rhinosinusitis and Raises $293 Million in IPOMarch 12, 2025 | quiverquant.comUpstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsMarch 12, 2025 | globenewswire.comUPB Upstream Bio, Inc.March 8, 2025 | seekingalpha.comPiper Sandler Remains a Buy on Upstream Bio, Inc. (UPB)March 4, 2025 | markets.businessinsider.comUpstream Bio to Present at Upcoming March Investor ConferencesFebruary 25, 2025 | globenewswire.comUpstream Bio (UPB) Projected to Post Earnings on ThursdayUpstream Bio (NASDAQ:UPB) will be releasing earnings before the market opens on Thursday, February 27, Financial Modeling Prep reports.February 22, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Reaches New 1-Year Low - What's Next?Upstream Bio (NASDAQ:UPB) Hits New 12-Month Low - Here's What HappenedFebruary 5, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Trading Down 7.3% - Time to Sell?Upstream Bio (NASDAQ:UPB) Stock Price Down 7.3% - Time to Sell?February 3, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Stock Price Up 9.4% - Here's What HappenedUpstream Bio (NASDAQ:UPB) Stock Price Up 9.4% - Time to Buy?January 30, 2025 | marketbeat.comMoody Aldrich Partners LLC Makes New Investment in Upstream Bio, Inc. (NASDAQ:UPB)Moody Aldrich Partners LLC purchased a new stake in Upstream Bio, Inc. (NASDAQ:UPB - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 74,773 shares of the company's stock, valued at approximately $1,229,000. Moody Aldrich PartnersJanuary 29, 2025 | marketbeat.comUpstream Bio, Inc. (UPB)January 25, 2025 | ca.finance.yahoo.comUpstream Bio (NASDAQ:UPB) Hits New 52-Week Low - Time to Sell?Upstream Bio (NASDAQ:UPB) Sets New 52-Week Low - Here's WhyJanuary 25, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Shares Down 3.9% - Here's What HappenedUpstream Bio (NASDAQ:UPB) Shares Down 3.9% - Here's WhyJanuary 24, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Shares Down 10.4% - Here's WhyUpstream Bio (NASDAQ:UPB) Trading Down 10.4% - Here's WhyJanuary 13, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Reaches New 12-Month Low - Should You Sell?Upstream Bio (NASDAQ:UPB) Reaches New 12-Month Low - Should You Sell?January 10, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Shares Down 7% - Should You Sell?Upstream Bio (NASDAQ:UPB) Shares Down 7% - Time to Sell?January 6, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Trading 8.5% Higher - Still a Buy?Upstream Bio (NASDAQ:UPB) Trading Up 8.5% - What's Next?January 3, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Trading Down 3% - Here's What HappenedUpstream Bio (NASDAQ:UPB) Trading Down 3% - Here's What HappenedDecember 26, 2024 | marketbeat.comUpstream Bio (NASDAQ:UPB) Shares Up 5.7% - Time to Buy?Upstream Bio (NASDAQ:UPB) Stock Price Up 5.7% - Still a Buy?December 23, 2024 | marketbeat.comUpstream Bio (NASDAQ:UPB) Reaches New 52-Week Low - Should You Sell?Upstream Bio (NASDAQ:UPB) Reaches New 12-Month Low - What's Next?December 18, 2024 | marketbeat.comUpstream Bio (NASDAQ:UPB) Shares Gap Down - Should You Sell?Upstream Bio (NASDAQ:UPB) Shares Gap Down - Should You Sell?December 17, 2024 | marketbeat.comUpstream Bio Appoints Allison Ambrose as General CounselDecember 17, 2024 | markets.businessinsider.comUpstream Bio (NASDAQ:UPB) Shares Down 5% - Time to Sell?Upstream Bio (NASDAQ:UPB) Stock Price Down 5% - What's Next?December 16, 2024 | marketbeat.comUpstream Bio to join Russell 2000 indexDecember 16, 2024 | msn.comUpstream Bio: Treating Respiratory Disorders With TSLP Targeting DifferentiationDecember 16, 2024 | seekingalpha.comUpstream Bio Announces Addition to Russell 2000® IndexDecember 16, 2024 | globenewswire.comUpstream Bio: Attractive, But Let's Wait For More Data And Lock-Up ExpiryDecember 7, 2024 | seekingalpha.comUpstream Bio to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 22, 2024 | finance.yahoo.comUpstream Bio, Inc.'s (NASDAQ:UPB) Quiet Period Set To End on November 20thUpstream Bio's (NASDAQ:UPB - Get Free Report) quiet period will expire on Wednesday, November 20th. Upstream Bio had issued 15,000,000 shares in its initial public offering on October 11th. The total size of the offering was $255,000,000 based on an initial share price of $17.00. During the company's quiet period, underwriters and any insiders that worked on the IPO are restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.November 13, 2024 | marketbeat.comUpstream Bio Inc UPBNovember 12, 2024 | morningstar.comBrokers Set Expectations for Upstream Bio Q4 EarningsUpstream Bio, Inc. (NASDAQ:UPB - Free Report) - Analysts at William Blair issued their Q4 2025 earnings per share (EPS) estimates for Upstream Bio in a research report issued on Thursday, November 7th. William Blair analyst M. Phipps anticipates that the company will post earnings per share of ($November 11, 2024 | marketbeat.comUpstream Bio Advances Clinical Trials, Strengthens FinancialsNovember 9, 2024 | tipranks.comWilliam Blair Weighs in on Upstream Bio Q4 EarningsUpstream Bio, Inc. (NASDAQ:UPB - Free Report) - Analysts at William Blair issued their Q4 2024 earnings per share (EPS) estimates for Upstream Bio in a report issued on Tuesday, November 5th. William Blair analyst M. Phipps expects that the company will post earnings of ($0.42) per share for theNovember 7, 2024 | marketbeat.comDiscover the 3 Best-Performing Biotech IPO Stocks of 2024Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.November 6, 2024 | marketbeat.comUpstream Bio (NASDAQ:UPB) Earns Overweight Rating from Analysts at Piper SandlerPiper Sandler initiated coverage on shares of Upstream Bio in a report on Tuesday. They issued an "overweight" rating and a $75.00 price target on the stock.November 5, 2024 | marketbeat.com Get Upstream Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for UPB and its competitors with MarketBeat's FREE daily newsletter. Email Address UPB Media Mentions By Week UPB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UPB News Sentiment▼0.770.73▲Average Medical News Sentiment UPB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UPB Articles This Week▼21▲UPB Articles Average Week Get Upstream Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for UPB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VCEL News TWST News MTSR News SDGR News DNLI News MIRM News TARS News BEAM News NAMS News KYMR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UPB) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Upstream Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Upstream Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy UPB Stock Free UPB Stock Alerts